Skip to main content
    K

    Krystal Biotech Inc (KRYS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $297.90
    -7.33 (-2.40%)

    Market Cap: $9.05B

    Last updated: Nov 17, 2026 at 4:20 PM ET

    Krystal Biotech Inc (KRYS) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Krystal Biotech (KRYS) has a latest price of $297.90 on Nov 17, 2026, 22.1% below its 52-week high of $382.54. Its price rose 48.1% over the past 12 months. The month-end price rose 3,232.9% since Sep 2017, a compound annual rate of 47.1%.

    Price Chart

    From Sep 2017 to Oct 2026, its highest month-end close was $371.67 in Jun 2026 and its lowest $9.61 in Apr 2018, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart KRYS with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for KRYS.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 10.5%, and over 6 months it rose 2.1%. The month-end price rose 184.3% over the 3 years through Oct 2026, a compound annual rate of 41.7%.

    PeriodChange
    1 month-5.9%
    3 months-10.5%
    6 months+2.1%
    12 months+48.1%
    12 months, with dividends+48.1%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+184.3%+41.7%
    5 years+563.4%+46.0%
    Since Sep 2017+3,232.9%+47.1%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2019, when the price rose 166.5%, and its weakest was 2020, when it rose 8.3%.

    YearCloseChange
    2026 through Oct 2026$332.29+34.8%
    2025$246.54+57.4%
    2024$156.66+26.3%
    2023$124.06+56.6%
    2022$79.22+13.3%
    2021$69.95+16.6%
    2020$60.00+8.3%
    2019$55.38+166.5%
    2018$20.78+97.5%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 8.5% below its 50-day average of $325.56 and 3.8% below its 200-day average of $309.80.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$297.90
    52-week high$382.54-22.1%
    52-week low$203.18+46.6%
    50-day average$325.56-8.5%
    200-day average$309.80-3.8%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 42.3%.

    MeasureValue
    1-year beta0.76
    Largest fall, 1 year-21.8%
    Largest fall, 3 years-42.3%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About KRYS

    What is KRYS's 1-year price change?

    Krystal Biotech's price rose 48.1% over the past 12 months. With dividends included, the 12-month total return was 48.1%.

    What is KRYS's 5-year price change?

    Krystal Biotech's month-end price rose 563.4% over the 5 years through Oct 2026, a compound annual rate of 46.0%. These figures leave out dividends.

    What is KRYS's 52-week high and low?

    Krystal Biotech's 52-week high is $382.54 and its 52-week low is $203.18. Its latest price of $297.90 on Nov 17, 2026 is 22.1% below the high.

    What is KRYS's beta?

    Krystal Biotech's 1-year beta against the S&P 500 is 0.76, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 21.8%.

    Is the KRYS chart free?

    Yes. Advanced Charting for KRYS is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.